112 related articles for article (PubMed ID: 25141261)
1. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.
Egger M; McNally L; Nitz J; McMasters KM; Gomez-Gutierrez JG
Hum Gene Ther Clin Dev; 2014 Aug; ():. PubMed ID: 25141261
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.
Egger ME; McNally LR; Nitz J; McMasters KM; Gomez-Gutierrez JG
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):186-95. PubMed ID: 25238278
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells.
Gomez-Gutierrez JG; Souza V; Hao HY; Montes de Oca-Luna R; Dong YB; Zhou HS; McMasters KM
Cancer Biol Ther; 2006 Jul; 5(7):875-83. PubMed ID: 16861905
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated expression of mutated forkhead human transcription like-1 suppresses tumor growth in a mouse melanoma xenograft model.
Gomez-Gutierrez JG; Egger ME; Hao H; Zhou HS; McMasters KM
Cancer Biol Ther; 2012 Oct; 13(12):1195-204. PubMed ID: 22892845
[TBL] [Abstract][Full Text] [Related]
5. The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.
Reuland SN; Goldstein NB; Partyka KA; Cooper DA; Fujita M; Norris DA; Shellman YG
PLoS One; 2011; 6(8):e24294. PubMed ID: 21897876
[TBL] [Abstract][Full Text] [Related]
6. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Thangasamy T; Sittadjody S; Mitchell GC; Mendoza EE; Radhakrishnan VM; Limesand KH; Burd R
BMC Cancer; 2010 Jun; 10():282. PubMed ID: 20540768
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
Yang M; Yang C; Tao Y; Tang J; Huang Q; Guo W; Feng S; Jiang A; Xu X; Jiang G; Liu Y
Cancer Med; 2018 Dec; 7(12):5928-5942. PubMed ID: 30406970
[TBL] [Abstract][Full Text] [Related]
8. Activated forkhead transcription factor inhibits neointimal hyperplasia after angioplasty through induction of p27.
Park KW; Kim DH; You HJ; Sir JJ; Jeon SI; Youn SW; Yang HM; Skurk C; Park YB; Walsh K; Kim HS
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):742-7. PubMed ID: 15662024
[TBL] [Abstract][Full Text] [Related]
9. Involvement of FKHRL1 in melanoma cell survival and death.
Hilmi C; Larribere L; Deckert M; Rocchi S; Giuliano S; Bille K; Ortonne JP; Ballotti R; Bertolotto C
Pigment Cell Melanoma Res; 2008 Apr; 21(2):139-46. PubMed ID: 18426407
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.
Shin I; Bakin AV; Rodeck U; Brunet A; Arteaga CL
Mol Biol Cell; 2001 Nov; 12(11):3328-39. PubMed ID: 11694570
[TBL] [Abstract][Full Text] [Related]
12. Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways.
Dai C; Zhang B; Liu X; Guo K; Ma S; Cai F; Yang Y; Yao Y; Feng M; Bao X; Deng K; Jiao Y; Wei Z; Junji W; Xing B; Lian W; Wang R
Int J Cancer; 2013 Oct; 133(8):1982-93. PubMed ID: 23564480
[TBL] [Abstract][Full Text] [Related]
13. IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide.
Ramcharan R; Aleksic T; Kamdoum WP; Gao S; Pfister SX; Tanner J; Bridges E; Asher R; Watson AJ; Margison GP; Woodcock M; Repapi E; Li JL; Middleton MR; Macaulay VM
Oncotarget; 2015 Nov; 6(37):39877-90. PubMed ID: 26497996
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.
Naumann SC; Roos WP; Jöst E; Belohlavek C; Lennerz V; Schmidt CW; Christmann M; Kaina B
Br J Cancer; 2009 Jan; 100(2):322-33. PubMed ID: 19127257
[TBL] [Abstract][Full Text] [Related]
15. Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy.
Makita K; Hara H; Sano E; Okamoto Y; Ochiai Y; Harada T; Ueda T; Nakayama T; Aizawa S; Yoshino A
Int J Oncol; 2019 May; 54(5):1864-1874. PubMed ID: 30864696
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
Jiang G; Sun C; Li RH; Wei ZP; Zheng JN; Liu YQ
J Cancer Res Clin Oncol; 2015 Jan; 141(1):75-85. PubMed ID: 25103017
[TBL] [Abstract][Full Text] [Related]
18. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
Li M; Liang RF; Wang X; Mao Q; Liu YH
Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909
[TBL] [Abstract][Full Text] [Related]
19. A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells
Liang Z; Yang CS; Gu F; Zhang LS
Oncol Lett; 2017 Jun; 13(6):4185-4189. PubMed ID: 28599419
[TBL] [Abstract][Full Text] [Related]
20. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
